Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Luis A. Alvarez‐Sala Walther"'
Autor:
Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Luis-Antonio Alvarez-Sala-Walther, Manuel Rubio-Rivas, Francisco Navarro-Romero, Vicente Giner Galvañ, Lucía de Jorge-Huerta, Eva Fonseca Aizpuru, Gema María García García, José Luis Beato Pérez, Paula María Pesqueira Fontan, Arturo Artero Mora, Juan Antonio Vargas Núñez, Nuria Ramírez Perea, José Miguel García Bruñén, Emilia Roy Vallejo, Isabel Perales-Fraile, Ricardo Gil Sánchez, José López Castro, Ángel Luis Martínez González, Luis Felipe Díez García, Marina Aroza Espinar, José-Manuel Casas-Rojo, Jesús Millán Núñez-Cortés
Publikováno v:
Viruses, Vol 16, Iss 3, p 335 (2024)
Background: This study aimed to validate the role of the D-dimer to lymphocyte ratio (DLR) for mortality prediction in a large national cohort of hospitalized coronavirus disease 2019 (COVID-19) patients. Methods: A retrospective, multicenter, observ
Externí odkaz:
https://doaj.org/article/3ed68a04ffa7404bb6ed46bfc936899e
Autor:
Alejandra García-García, Luis A. Alvarez-Sala-Walther, Hae-Young Lee, Cristina Sierra, Domingo Pascual-Figal, Miguel Camafort
Publikováno v:
The Korean Journal of Internal Medicine, Vol 37, Iss 1, Pp 37-47 (2022)
The incidence and prevalence of heart failure (HF) is increasing worldwide, leading to high morbidity and mortality. The global management of HF involves lifestyle changes in addition to pharmacological treatments. Changes include exercise and dietar
Externí odkaz:
https://doaj.org/article/c914d4368614479281950cf5a131d80a
Autor:
Irene García-Fernández-Bravo, Ana Torres-Do-Rego, Antonio López-Farré, Francisco Galeano-Valle, Pablo Demelo-Rodriguez, Luis A. Alvarez-Sala-Walther
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid sequestrants, and PCSK9 inhibitors. As new evidence emerges from n
Externí odkaz:
https://doaj.org/article/c759242c5542401b8fe298fde48a7027
Autor:
Cristina Ausín‐García, Eva Cervilla‐Muñoz, Pablo Demelo‐Rodríguez, María Victoria Villalba‐García, Luis A. Alvarez‐Sala Walther
Publikováno v:
International Journal of Rheumatic Diseases. 26:793-796
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fe2d106fea1a5a058d86f63475385e4
https://doi.org/10.1111/1756-185x.14544
https://doi.org/10.1111/1756-185x.14544
Autor:
Philippe Moulin, Robert Dufour, Maurizio Averna, Marcello Arca, Angelo B. Cefalù, Davide Noto, Laura D’Erasmo, Alessia Di Costanzo, Christophe Marçais, Luis Antonio Alvarez-Sala Walther, Maciej Banach, Jan Borén, Robert Cramb, Ioanna Gouni-Berthold, Elizabeth Hughes, Colin Johnson, Xavier Pintó, Željko Reiner, Jeanine Roeters van Lennep, Handrean Soran, Claudia Stefanutti, Erik Stroes, Eric Bruckert
Publikováno v:
Data in Brief, Vol 21, Iss , Pp 1334-1336 (2018)
Data presented in this article are supplementary material to our article entitled “Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an “FCS Score” (Moulin et al
Externí odkaz:
https://doaj.org/article/e3151c823e6a4206b9afc2f7a8d0b1f8
Autor:
Neera Toledo-Samaniego, Crhistian Mario Oblitas, Eduardo Peñaloza-Martínez, Jorge del-Toro-Cervera, Luis Antonio Alvarez-Sala-Walther, Pablo Demelo-Rodríguez, Francisco Galeano-Valle
Publikováno v:
Journal of Thrombosis and Thrombolysis. 54:162-171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::857f0ecc2dfe5417b0d1429ad1a23862
https://doi.org/10.1007/s11239-022-02637-1
https://doi.org/10.1007/s11239-022-02637-1
Autor:
Miguel Camafort, Alejandra García-García, Domingo A. Pascual-Figal, Luis A Alvarez-Sala-Walther, Hae Young Lee, Cristina Sierra
Publikováno v:
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine, Vol 37, Iss 1, Pp 37-47 (2022)
The Korean Journal of Internal Medicine, Vol 37, Iss 1, Pp 37-47 (2022)
The incidence and prevalence of heart failure (HF) is increasing worldwide, leading to high morbidity and mortality. The global management of HF involves lifestyle changes in addition to pharmacological treatments. Changes include exercise and dietar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed7e61cee91af94fe131b69a5781942
https://pubmed.ncbi.nlm.nih.gov/34482681
https://pubmed.ncbi.nlm.nih.gov/34482681
Autor:
Ana Torres do Rego, Alejandro Parra Virto, Sandra Piqueras Ruiz, Pablo Demelo Rodríguez, Luis Antonio Alvarez-Sala Walther
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 32:30-32
Inhibitors of the protein PCSK9, available since 2015, are capable of reducing the concentration of low density lipoprotein cholesterol by 40 to 70%, thus reducing the cardiovascular risk. The present case reports an adverse cardiovascular event that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0634eadb3dc98528bd3f0de7f5f822f2
https://doi.org/10.1016/j.arteri.2019.04.003
https://doi.org/10.1016/j.arteri.2019.04.003
Autor:
Alejandro Parra Virto, Luis Antonio Alvarez-Sala Walther, Sandra Piqueras Ruiz, Pablo Demelo Rodríguez, Ana Torres do Rego
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 32:29-31
Inhibitors of the protein PCSK9, available since 2015, are capable of reducing the concentration of low density lipoprotein cholesterol by 40–70%, thus reducing the cardiovascular risk. The present case reports an adverse cardiovascular event that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc8a792c90b38745dbfa382e016bba8
https://doi.org/10.1016/j.artere.2019.04.002
https://doi.org/10.1016/j.artere.2019.04.002
Autor:
Jorge del Toro-Cervera, Eduardo Peñaloza-Martínez, Pablo Demelo-Rodríguez, Cristina Llamazares-Mendo, Alberto M. Marra, Marco Proietti, Luis Antonio Alvarez-Sala Walther, Guillermo Soria Fernández-Llamazares
Publikováno v:
Annals of Medicine. 50:666-674
The importance of assessing the probability of venous thromboembolism recurrence, a condition that includes deep vein thrombosis and pulmonary embolism, lies in the fact that it is the most important factor in deciding the duration of anticoagulant t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8608b0a5a1eb4c456cd4272b66cff9
https://doi.org/10.1080/07853890.2018.1538564
https://doi.org/10.1080/07853890.2018.1538564